The use of two measures of health-related quality of life in HIV-infected individuals: A cross-sectional comparison

被引:33
作者
Copfer, AE
Ampel, NM
Hughes, TE
Gregor, KJ
Dols, CL
Coons, SJ
Colgan, K
Wu, AW
机构
[1] VET AFFAIRS MED CTR, MED SERV 111, TUCSON, AZ 85723 USA
[2] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA
[3] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, BALTIMORE, MD 21218 USA
[4] UNIV ARIZONA, COLL PHARM, TUCSON, AZ 85721 USA
关键词
Acquired Immunodeficiency Syndrome; health status; HIV-infection; quality of life; questionnaires;
D O I
10.1007/BF00434750
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Two measures of health-related quality of life in 65 HIV-infected individuals were compared in a cross-sectional design. The Quality of Well-Being Scale (QWB) results in a single score ranging from death to perfect health. The MOS-HIV Health Survey (MOS-HIV, 34-item version) gives scores in 11 dimensions. The QWB score distinguished subjects with AIDS from those who were asymptomatic (p=0.027). For the seven multi-item scales of the MOS-HIV, Cronbach's alpha ranged from 0.85-0.95, indicating good internal consistency reliability. Clinical HIV-infection status was significantly associated with the dimensions of Overall Health (p=0.002), Role Function (p=0.022), Social Function (p=0.037), Energy/Fatigue (p=0.027) and Health Distress (p=0.025). All eleven dimensions of the MOS-HIV were significantly correlated with the QWB score (Spearman's coefficient=0.405-0.670; for all, p<0.01) and the QWB score could be predicted from the MOS-HIV dimension scores using multiple regression. The QWB and the MOS-HIV may be useful in assessing health-related quality of life in patients infected with HIV.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 26 条
[1]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[2]  
[Anonymous], MED DECIS MAK
[3]  
BOZZETTE SA, 1995, JAMA-J AM MED ASSOC, V273, P295, DOI 10.1001/jama.273.4.295
[4]   THE RELIABILITY AND VALIDITY OF 2 HIV-SPECIFIC HEALTH-RELATED QUALITY-OF-LIFE MEASURES - A PRELIMINARY-ANALYSIS [J].
BURGESS, A ;
DAYER, M ;
CATALAN, J ;
HAWKINS, D ;
GAZZARD, B .
AIDS, 1993, 7 (07) :1001-1008
[5]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[6]   LONGITUDINAL-STUDY ON THE QUALITY-OF-LIFE OF SYMPTOMATIC HIV-INFECTED PATIENTS IN A TRIAL OF ZIDOVUDINE VERSUS ZIDOVUDINE AND INTERFERON-ALPHA [J].
DEBOER, JB ;
VANDAM, FSAM ;
SPRANGERS, MAG ;
FRISSEN, PHJ ;
LANGE, JMA .
AIDS, 1993, 7 (07) :947-953
[7]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172
[8]   QUALITY-OF-LIFE EVALUATION IN A CLINICAL-TRIAL OF ZIDOVUDINE THERAPY IN PATIENTS WITH MILDLY SYMPTOMATIC HIV-INFECTION [J].
GELBER, RD ;
LENDERKING, WR ;
COTTON, DJ ;
COLE, BF ;
FISCHL, MA ;
GOLDHIRSCH, A ;
TESTA, MA .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) :961-966
[9]   A CONTROLLED TRIAL OF EARLY VERSUS LATE TREATMENT WITH ZIDOVUDINE IN SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - RESULTS OF THE VETERANS AFFAIRS COOPERATIVE STUDY [J].
HAMILTON, JD ;
HARTIGAN, PM ;
SIMBERKOFF, MS ;
DAY, PL ;
DIAMOND, GR ;
DICKINSON, GM ;
DRUSANO, GL ;
EGORIN, MJ ;
GEORGE, WL ;
GORDIN, FM ;
HAWKES, CA ;
JENSEN, PC ;
KLIMAS, NG ;
LABRIOLA, AM ;
LAHART, CJ ;
OBRIEN, WA ;
OSTER, CN ;
WEINHOLD, KJ ;
WRAY, NP ;
ZOLLAPAZNER, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (07) :437-443
[10]   VALIDITY OF A QUALITY OF WELL-BEING SCALE AS AN OUTCOME MEASURE IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
KAPLAN, RM ;
ATKINS, CJ ;
TIMMS, R .
JOURNAL OF CHRONIC DISEASES, 1984, 37 (02) :85-95